CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$192M
1-Year Return
17.05%
This Quarter Return
-2.78%
1 Year Return
+17.05%
3 Year Return
+45.89%
5 Year Return
+105.96%
10 Year Return
+138.93%
AUM
$550M
AUM Growth
-$25.8M
(-4.5%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
8.93%
Holding
683
New
116
Increased
168
Reduced
251
Closed
120
Top Buys
| 1 |
Intel
INTC
|
$2.17M |
| 2 |
AT&T
T
|
$2.1M |
| 3 |
Chubb
CB
|
$1.93M |
| 4 |
Clorox
CLX
|
$1.89M |
| 5 |
HCA Healthcare
HCA
|
$1.88M |
Top Sells
| 1 |
Wabtec
WAB
|
$2.95M |
| 2 |
Marathon Petroleum
MPC
|
$2.83M |
| 3 |
Occidental Petroleum
OXY
|
$2.71M |
| 4 |
Dow Inc
DOW
|
$2.68M |
| 5 |
Citizens Financial Group
CFG
|
$2.32M |
Sector Composition
| 1 | Technology | 17.49% |
| 2 | Financials | 16.43% |
| 3 | Healthcare | 14.65% |
| 4 | Industrials | 13.25% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Advanced Micro Devices
AMD
$245B
| $248K | 0.05% |
2,408
| – | – |
|
477
Hewlett Packard
HPE
$31B
| $242K | 0.04% |
13,956
| – | – |
|
478
J.M. Smucker
SJM
$12B
| $235K | 0.04% |
1,908
+163
| +9% | +$20K |
|
479
Starbucks
SBUX
$97.1B
| $230K | 0.04% |
2,521
+50
| +2% | +$4.56K |
|
480
Arcus Biosciences
RCUS
$1.3B
| $230K | 0.04% |
12,787
-98
| -0.8% | -$1.76K |
|
|
SAGE
481
DELISTED
Sage Therapeutics
SAGE
| $228K | 0.04% |
+11,066
| New | +$228K |
|
482
Cambium Networks
CMBM
$18.4M
| $225K | 0.04% |
30,671
-214
| -0.7% | -$1.57K |
|
483
Broadcom
AVGO
$1.58T
| $222K | 0.04% |
2,670
-60
| -2% | -$4.98K |
|
484
Entrada Therapeutics
TRDA
$201M
| $221K | 0.04% |
+13,977
| New | +$221K |
|
485
Diamondback Energy
FANG
$40.2B
| $221K | 0.04% |
+1,424
| New | +$221K |
|
486
Cboe Global Markets
CBOE
$24.3B
| $219K | 0.04% |
+1,402
| New | +$219K |
|
487
Assertio
ASRT
$76.8M
| $217K | 0.04% |
84,862
-1,582
| -2% | -$4.05K |
|
488
Air Products & Chemicals
APD
$64.5B
| $210K | 0.04% |
740
| – | – |
|
489
Verastem
VSTM
$663M
| $205K | 0.04% |
+25,274
| New | +$205K |
|
490
Lowe's Companies
LOW
$151B
| $204K | 0.04% |
982
-4,807
| -83% | -$999K |
|
491
Rollins
ROL
$27.4B
| $204K | 0.04% |
5,460
+260
| +5% | +$9.71K |
|
492
CF Industries
CF
$13.7B
| $203K | 0.04% |
2,372
-1,493
| -39% | -$128K |
|
493
Regenxbio
RGNX
$490M
| $196K | 0.04% |
11,921
-153
| -1% | -$2.52K |
|
494
Relay Therapeutics
RLAY
$710M
| $194K | 0.04% |
+23,088
| New | +$194K |
|
|
PNT
495
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $190K | 0.03% |
28,474
-373
| -1% | -$2.49K |
|
|
PSTX
496
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $190K | 0.03% |
79,709
-1,270
| -2% | -$3.02K |
|
497
Dyne Therapeutics
DYN
$2.02B
| $188K | 0.03% |
20,938
-297
| -1% | -$2.66K |
|
498
MindMed
MNMD
$702M
| $178K | 0.03% |
56,957
+479
| +0.8% | +$1.5K |
|
|
DCPH
499
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $170K | 0.03% |
+13,379
| New | +$170K |
|
500
Atara Biotherapeutics
ATRA
$90.7M
| $170K | 0.03% |
4,588
-58
| -1% | -$2.15K |
|